Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 05 - 11 save search
P-BCMA-ALLO1 — A Fully Allogeneic Stem Cell Memory T Cell (TSCM) CAR-T Therapy Targeting BCMA for the Treatment of Multiple Myeloma Shows Potent Anti-Tumor Activity
Published: 2021-05-11 (Crawled : 15:15) - poseida.com
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: -0.13%
H: 8.68%
C: 6.92%
treatment stem cell therapy car-t t-cell
Poseida Therapeutics Presents Encouraging Preclinical Data Across its CAR-T and Gene Therapy Programs at the American Society of Gene and Cell Therapy 2021 Virtual Annual Meeting
Published: 2021-05-11 (Crawled : 15:00) - biospace.com/
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: -0.13%
H: 8.68%
C: 6.92%
gene therapy therapy car-t gene therapies preclinical pre-clinical
Akouos Presents Nonclinical Data Supporting Future Clinical Development of AK-OTOF and AK-antiVEGF at the American Society of Gene and Cell Therapy 24th Annual Meeting
Published: 2021-05-11 (Crawled : 13:00) - biospace.com/
AKUS | $13.29 1.07% 3.46%
|
Health Technology
|
| O: -2.56%
H: 10.54%
C: 6.48%
therapy
Freeline Presents Data Highlighting Platform Technology at the American Society of Gene and Cell Therapy Annual Meeting 2021
Published: 2021-05-11 (Crawled : 12:00) - biospace.com/
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: -0.99%
H: 8.99%
C: -2.67%
therapy technology
Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID
Published: 2021-05-11 (Crawled : 12:00) - biospace.com/
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -2.72%
H: 5.8%
C: 5.6%
gene therapy therapy gene therapies
AGTC Reports Process Development Advances for Manufacturing its XLRP Gene Therapy Candidate in Two Abstracts at ASGCT
Published: 2021-05-11 (Crawled : 12:00) - biospace.com/
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -5.51%
H: 8.06%
C: 2.22%
gene therapy therapy gene therapies
Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update
Published: 2021-05-11 (Crawled : 12:00) - biospace.com/
TSHA | $2.265 -6.02% -6.4% 1.8M
|
Health Technology
|
| O: -2.14%
H: 8.81%
C: 4.58%
financial results gene therapies results therapy gene therapy
Compugen to Participate at SITC's Targets for Cancer Immunotherapy: A Deep Dive Seminar Series
Published: 2021-05-11 (Crawled : 12:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -3.35%
H: 4.62%
C: 2.45%
immunotherapy therapy cancer
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
ARCO | $10.9 1.3% -3.39% 1.1M
|
Consumer Services
NOV 4 | $18.75 1.35% -6.67% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.